Christopher Raymond Lyddon
Plus aucun poste en cours
Profil
Christopher Raymond Lyddon was a Non-Executive Director at Altacor Ltd., Chief Financial Officer & Secretary at Procognia Ltd., and a Principal at BDO Binder Hamlyn, Roche Diagnostics GmbH, and GE Healthcare Ltd.
(United Kingdom).
Anciens postes connus de Christopher Raymond Lyddon
| Sociétés | Poste | Fin |
|---|---|---|
Altacor Ltd.
 Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Directeur/Membre du Conseil | - |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Corporate Officer/Principal | - |
| BDO Binder Hamlyn | Corporate Officer/Principal | - |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - |
Procognia Ltd.
 Procognia Ltd. Miscellaneous Commercial ServicesCommercial Services Procognia Ltd. provides technology for the development of glycoprotein drugs. It uses protein arrays to understand the function of proteins and their post-translational modifications. Utilizing technologies based around proteins arrays, they provide both the means for disease mechanisms and the discovery and development of drugs to treat those diseases. Procognia uses protein arrays to understand the function of proteins and their post-translational modifications, particularly glycosylation | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Procognia Ltd.
Procognia Ltd. Miscellaneous Commercial ServicesCommercial Services Procognia Ltd. provides technology for the development of glycoprotein drugs. It uses protein arrays to understand the function of proteins and their post-translational modifications. Utilizing technologies based around proteins arrays, they provide both the means for disease mechanisms and the discovery and development of drugs to treat those diseases. Procognia uses protein arrays to understand the function of proteins and their post-translational modifications, particularly glycosylation | Commercial Services |
| BDO Binder Hamlyn | Commercial Services |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
Altacor Ltd.
Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Health Technology |
